GRIN2A c.2954C>T ;(p.P985L)

Variant ID: 16-9858447-G-A

NM_001134407.1(GRIN2A):c.2954C>T;(p.P985L)

This variant was identified in 1 publication

View GRCh38 version.



Variant-Specific Resource Links:
gnomAD v2.1.1
Mutalizer Name Checker
Google
UCSC Genome Browser
ClinVar
dbSNP

Publications:

Phase II trial of MEK inhibitor selumetinib (AZD6244, ARRY-142886) in patients with BRAFV600E/K-mutated melanoma.

Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
Catalanotti, Federica F; Solit, David B DB; Pulitzer, Melissa P MP; Berger, Michael F MF; Scott, Sasinya N SN; Iyriboz, Tunc T; Lacouture, Mario E ME; Panageas, Katherine S KS; Wolchok, Jedd D JD; Carvajal, Richard D RD; Schwartz, Gary K GK; Rosen, Neal N; Chapman, Paul B PB
Publication Date: 2013-04-15

Variant appearance in text: GRIN2A: P985L
PubMed Link: 23444215
Variant Present in the following documents:
  • Main text
View BVdb publication page